About Vermicon
Vermicon is a company based in Munchen (Germany) founded in 1997 by Jiri Snaidr. Vermicon operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter Munchen, Germany
- Founders Jiri Snaidr
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vermicon Aktiengesellschaft
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$122.66 K (USD), Grant
Oct 01, 2016
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Vermicon
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Vermicon
Investors in Vermicon
Vermicon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Vermicon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vermicon
Investment portfolio details for Vermicon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vermicon
Detailed financials for Vermicon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vermicon Comparisons
Peer comparison for Vermicon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vermicon
Vermicon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
Electrophoresis-based in vitro diagnostics products are developed and provided.
|
Detailed competitors of Vermicon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vermicon
Complete news archive for Vermicon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vermicon
Vermicon was founded in 1997 and raised its 1st funding round 19 years after it was founded.
Vermicon is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Jiri Snaidr is the current CEO of Vermicon. They have also founded this company.
Vermicon was founded in 1997 in Munich, Germany, and operates in the biotechnology sector focused on microbial detection. Proprietary VIT gene probe technology is utilized to diagnose microorganisms, with products and services including the Scan VITSystem, Flow VIT Solution for Alicyclobacillus, and CyFlow BrettCount. These offerings support identification and analysis in various applications.
Vermicon's top competitors include Neogen, Qiagen and Parse Biosciences.
Vermicon has 1 investor. Key investors include European Union.